Advertisement

Index by author

September 01, 1988; Volume 34,Issue 3

A

  1. Adamik, R

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

  2. Antkiewicz-Michaluk, L

    1. Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands.
      L Antkiewicz-Michaluk, A Guidotti and K E Krueger
      Molecular Pharmacology September 1988, 34 (3) 272-278;

  3. Artymyshyn, R P

    1. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
      G R Luthin, J Harkness, R P Artymyshyn and B B Wolfe
      Molecular Pharmacology September 1988, 34 (3) 327-333;

B

  1. Bahouth, S W

    1. Subclassification of beta-adrenergic receptors of rat fat cells: a re-evaluation.
      S W Bahouth and C C Malbon
      Molecular Pharmacology September 1988, 34 (3) 318-326;

  2. Bonhaus, D W

    1. N-methyl-D-aspartate receptor regulation of uncompetitive antagonist binding in rat brain membranes: kinetic analysis.
      D W Bonhaus and J O McNamara
      Molecular Pharmacology September 1988, 34 (3) 250-255;

  3. Borden, L A

    1. Mechanism of gamma-aminobutyric acid/benzodiazepine receptor turnover in neuronal cells: evidence for nonlysosomal degradation.
      L A Borden and D H Farb
      Molecular Pharmacology September 1988, 34 (3) 354-362;

C

  1. Camerman, A

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  2. Camerman, N

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  3. Chen, J

    1. Dihydropyridine Bay K 8644 activates T lymphocyte calcium-permeable channels.
      W Young, J Chen, F Jung and P Gardner
      Molecular Pharmacology September 1988, 34 (3) 239-244;

  4. Clark, J A

    1. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
      J A Clark, R Houghten and G W Pasternak
      Molecular Pharmacology September 1988, 34 (3) 308-317;

  5. Cowlen, M S

    1. Evidence for alpha 1-adrenergic receptor internalization in DDT1 MF-2 cells following exposure to agonists plus protein kinase C activators.
      M S Cowlen and M L Toews
      Molecular Pharmacology September 1988, 34 (3) 340-346;

D

  1. Dekant, W

    1. Metabolism and excretion of S-conjugates derived from hexachlorobutadiene in the isolated perfused rat kidney.
      D Schrenk, W Dekant and D Henschler
      Molecular Pharmacology September 1988, 34 (3) 407-412;

  2. Dingledine, R

    1. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology.
      T A Verdoorn and R Dingledine
      Molecular Pharmacology September 1988, 34 (3) 298-307;

E

  1. Edmondson, D E

    1. Effect of hypoxia on tert-butylhydroperoxide-induced oxidative injury in hepatocytes.
      D L Tribble, D P Jones and D E Edmondson
      Molecular Pharmacology September 1988, 34 (3) 413-420;

  2. Everson, R B

    1. Smoking-related alterations in epidermal growth factor and insulin receptors in human placenta.
      S L Wang, G W Lucier, R B Everson, G I Sunahara and K T Shiverick
      Molecular Pharmacology September 1988, 34 (3) 265-271;

F

  1. Farb, D H

    1. Mechanism of gamma-aminobutyric acid/benzodiazepine receptor turnover in neuronal cells: evidence for nonlysosomal degradation.
      L A Borden and D H Farb
      Molecular Pharmacology September 1988, 34 (3) 354-362;

  2. Fisher, J M

    1. Evidence for a copper:S-(methylthio)-L-homocysteine complex as a glutamine antagonist of cytidine triphosphate synthesis in L1210 murine leukemia cells.
      M Rabinovitz and J M Fisher
      Molecular Pharmacology September 1988, 34 (3) 401-406;

  3. Frenking, G

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  4. Freytag, S

    1. Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme.
      S Lenzen, S Freytag and U Panten
      Molecular Pharmacology September 1988, 34 (3) 395-400;

G

  1. Gardner, P

    1. Dihydropyridine Bay K 8644 activates T lymphocyte calcium-permeable channels.
      W Young, J Chen, F Jung and P Gardner
      Molecular Pharmacology September 1988, 34 (3) 239-244;

  2. Goldman, D W

    1. Conversion of 5-hydroperoxyeicosatetraenoic acid into leukotriene B4 by rat hepatocytes: a novel cellular source for leukotriene B4.
      J Gut, D W Goldman and J R Trudell
      Molecular Pharmacology September 1988, 34 (3) 256-264;

  3. Guidotti, A

    1. Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands.
      L Antkiewicz-Michaluk, A Guidotti and K E Krueger
      Molecular Pharmacology September 1988, 34 (3) 272-278;

  4. Gut, J

    1. Conversion of 5-hydroperoxyeicosatetraenoic acid into leukotriene B4 by rat hepatocytes: a novel cellular source for leukotriene B4.
      J Gut, D W Goldman and J R Trudell
      Molecular Pharmacology September 1988, 34 (3) 256-264;

H

  1. Halpern, J L

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

  2. Harkness, J

    1. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
      G R Luthin, J Harkness, R P Artymyshyn and B B Wolfe
      Molecular Pharmacology September 1988, 34 (3) 327-333;

  3. Henschler, D

    1. Metabolism and excretion of S-conjugates derived from hexachlorobutadiene in the isolated perfused rat kidney.
      D Schrenk, W Dekant and D Henschler
      Molecular Pharmacology September 1988, 34 (3) 407-412;

  4. Hess, M L

    1. The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum.
      E Okabe, C Odajima, R Taga, R C Kukreja, M L Hess and H Ito
      Molecular Pharmacology September 1988, 34 (3) 388-394;

  5. Hewlett, E L

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

  6. Hom, B E

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

  7. Houghten, R

    1. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
      J A Clark, R Houghten and G W Pasternak
      Molecular Pharmacology September 1988, 34 (3) 308-317;

I

  1. In, Y

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  2. Inoue, M

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  3. Ishida, T

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  4. Ito, H

    1. The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum.
      E Okabe, C Odajima, R Taga, R C Kukreja, M L Hess and H Ito
      Molecular Pharmacology September 1988, 34 (3) 388-394;

J

  1. Jones, D P

    1. Effect of hypoxia on tert-butylhydroperoxide-induced oxidative injury in hepatocytes.
      D L Tribble, D P Jones and D E Edmondson
      Molecular Pharmacology September 1988, 34 (3) 413-420;

  2. Juliano, R L

    1. Interactions of liposome-incorporated amphotericin B with kidney epithelial cell cultures.
      H J Krause and R L Juliano
      Molecular Pharmacology September 1988, 34 (3) 286-297;

  3. Jung, F

    1. Dihydropyridine Bay K 8644 activates T lymphocyte calcium-permeable channels.
      W Young, J Chen, F Jung and P Gardner
      Molecular Pharmacology September 1988, 34 (3) 239-244;

K

  1. Kanda, N

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  2. Karlish, S J

    1. Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
      D M Tal and S J Karlish
      Molecular Pharmacology September 1988, 34 (3) 245-249;

  3. Krause, H J

    1. Interactions of liposome-incorporated amphotericin B with kidney epithelial cell cultures.
      H J Krause and R L Juliano
      Molecular Pharmacology September 1988, 34 (3) 286-297;

  4. Krueger, K E

    1. Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands.
      L Antkiewicz-Michaluk, A Guidotti and K E Krueger
      Molecular Pharmacology September 1988, 34 (3) 272-278;

  5. Kukreja, R C

    1. The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum.
      E Okabe, C Odajima, R Taga, R C Kukreja, M L Hess and H Ito
      Molecular Pharmacology September 1988, 34 (3) 388-394;

L

  1. Lawson, J A

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  2. Leid, M

    1. Characterization of agonist radioligand interactions with porcine atrial A1 adenosine receptors.
      M Leid, M I Schimerlik and T F Murray
      Molecular Pharmacology September 1988, 34 (3) 334-339;

  3. Lenzen, S

    1. Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme.
      S Lenzen, S Freytag and U Panten
      Molecular Pharmacology September 1988, 34 (3) 395-400;

  4. Loew, G H

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  5. Lucier, G W

    1. Smoking-related alterations in epidermal growth factor and insulin receptors in human placenta.
      S L Wang, G W Lucier, R B Everson, G I Sunahara and K T Shiverick
      Molecular Pharmacology September 1988, 34 (3) 265-271;

  6. Luthin, G R

    1. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
      G R Luthin, J Harkness, R P Artymyshyn and B B Wolfe
      Molecular Pharmacology September 1988, 34 (3) 327-333;

M

  1. Ma, L Y

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  2. Malbon, C C

    1. Subclassification of beta-adrenergic receptors of rat fat cells: a re-evaluation.
      S W Bahouth and C C Malbon
      Molecular Pharmacology September 1988, 34 (3) 318-326;

  3. Manganiello, V C

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

  4. McNamara, J O

    1. N-methyl-D-aspartate receptor regulation of uncompetitive antagonist binding in rat brain membranes: kinetic analysis.
      D W Bonhaus and J O McNamara
      Molecular Pharmacology September 1988, 34 (3) 250-255;

  5. Moss, J

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

  6. Motulsky, H J

    1. The potency and kinetics of the beta-adrenergic receptors on human neutrophils.
      H Mueller, H J Motulsky and L A Sklar
      Molecular Pharmacology September 1988, 34 (3) 347-353;

  7. Mueller, H

    1. The potency and kinetics of the beta-adrenergic receptors on human neutrophils.
      H Mueller, H J Motulsky and L A Sklar
      Molecular Pharmacology September 1988, 34 (3) 347-353;

  8. Murray, T F

    1. Characterization of agonist radioligand interactions with porcine atrial A1 adenosine receptors.
      M Leid, M I Schimerlik and T F Murray
      Molecular Pharmacology September 1988, 34 (3) 334-339;

O

  1. Odajima, C

    1. The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum.
      E Okabe, C Odajima, R Taga, R C Kukreja, M L Hess and H Ito
      Molecular Pharmacology September 1988, 34 (3) 388-394;

  2. Ohishi, H

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  3. Ohmomo, Y

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  4. Okabe, E

    1. The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum.
      E Okabe, C Odajima, R Taga, R C Kukreja, M L Hess and H Ito
      Molecular Pharmacology September 1988, 34 (3) 388-394;

P

  1. Panten, U

    1. Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme.
      S Lenzen, S Freytag and U Panten
      Molecular Pharmacology September 1988, 34 (3) 395-400;

  2. Pasternak, G W

    1. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
      J A Clark, R Houghten and G W Pasternak
      Molecular Pharmacology September 1988, 34 (3) 308-317;

  3. Polgar, W

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  4. Price, S R

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

R

  1. Rabinovitz, M

    1. Evidence for a copper:S-(methylthio)-L-homocysteine complex as a glutamine antagonist of cytidine triphosphate synthesis in L1210 murine leukemia cells.
      M Rabinovitz and J M Fisher
      Molecular Pharmacology September 1988, 34 (3) 401-406;

S

  1. Schimerlik, M I

    1. Characterization of agonist radioligand interactions with porcine atrial A1 adenosine receptors.
      M Leid, M I Schimerlik and T F Murray
      Molecular Pharmacology September 1988, 34 (3) 334-339;

  2. Schrenk, D

    1. Metabolism and excretion of S-conjugates derived from hexachlorobutadiene in the isolated perfused rat kidney.
      D Schrenk, W Dekant and D Henschler
      Molecular Pharmacology September 1988, 34 (3) 407-412;

  3. Shiverick, K T

    1. Smoking-related alterations in epidermal growth factor and insulin receptors in human placenta.
      S L Wang, G W Lucier, R B Everson, G I Sunahara and K T Shiverick
      Molecular Pharmacology September 1988, 34 (3) 265-271;

  4. Sklar, L A

    1. The potency and kinetics of the beta-adrenergic receptors on human neutrophils.
      H Mueller, H J Motulsky and L A Sklar
      Molecular Pharmacology September 1988, 34 (3) 347-353;

  5. Sunahara, G I

    1. Smoking-related alterations in epidermal growth factor and insulin receptors in human placenta.
      S L Wang, G W Lucier, R B Everson, G I Sunahara and K T Shiverick
      Molecular Pharmacology September 1988, 34 (3) 265-271;

T

  1. Taga, R

    1. The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum.
      E Okabe, C Odajima, R Taga, R C Kukreja, M L Hess and H Ito
      Molecular Pharmacology September 1988, 34 (3) 388-394;

  2. Tal, D M

    1. Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
      D M Tal and S J Karlish
      Molecular Pharmacology September 1988, 34 (3) 245-249;

  3. Tanaka, A

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  4. Tanaka, C

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  5. Toews, M L

    1. Evidence for alpha 1-adrenergic receptor internalization in DDT1 MF-2 cells following exposure to agonists plus protein kinase C activators.
      M S Cowlen and M L Toews
      Molecular Pharmacology September 1988, 34 (3) 340-346;

  6. Toll, L

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  7. Tribble, D L

    1. Effect of hypoxia on tert-butylhydroperoxide-induced oxidative injury in hepatocytes.
      D L Tribble, D P Jones and D E Edmondson
      Molecular Pharmacology September 1988, 34 (3) 413-420;

  8. Trudell, J R

    1. Conversion of 5-hydroperoxyeicosatetraenoic acid into leukotriene B4 by rat hepatocytes: a novel cellular source for leukotriene B4.
      J Gut, D W Goldman and J R Trudell
      Molecular Pharmacology September 1988, 34 (3) 256-264;

  9. Tsai, S C

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

U

  1. Ueno, Y

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  2. Uyeno, E T

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

V

  1. Verdoorn, T A

    1. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology.
      T A Verdoorn and R Dingledine
      Molecular Pharmacology September 1988, 34 (3) 298-307;

W

  1. Wang, S L

    1. Smoking-related alterations in epidermal growth factor and insulin receptors in human placenta.
      S L Wang, G W Lucier, R B Everson, G I Sunahara and K T Shiverick
      Molecular Pharmacology September 1988, 34 (3) 265-271;

  2. Wolfe, B B

    1. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
      G R Luthin, J Harkness, R P Artymyshyn and B B Wolfe
      Molecular Pharmacology September 1988, 34 (3) 327-333;

Y

  1. Yamamoto, D

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  2. Young, W

    1. Dihydropyridine Bay K 8644 activates T lymphocyte calcium-permeable channels.
      W Young, J Chen, F Jung and P Gardner
      Molecular Pharmacology September 1988, 34 (3) 239-244;
Back to top

In this issue

Advertisement